Almaden Genomics

Interested in exploring biomarkers but unsure how to analyze RNA-sequencing data? Join us on August 6 as Almaden Genomics' Mark Kunitomi, Chief Scientific Officer, and Hannah Schuyler, Director of Business Development, showcase how biologists can leverage g.nome’s Guided Workflows to perform differential expression analyses from FASTQ files. You will learn how to uncover significant insights and drive your research forward. JOIN OUR WEBINAR TO LEARN HOW TO: 🧬️ Simplify RNASeq analysis: Generate visualizations from publicly fetched data with minimal effort. 🧬️ Confidently assess quality: Perform rigorous QC via simple visual reports. 🧬️ Identify biomarkers: Highlight strong candidates through differential expression analysis and gene set enrichment. Discover how to quickly and easily identify biomarkers using g.nome’s intuitive platform, even without extensive bioinformatics expertise. Register now: https://lnkd.in/gshV9yAT

Genotype imputation is essential in #genomicresearch, allowing researchers to predict unobserved genotypes and fill in gaps in genetic data, therefore improving the power and resolution of genetic association studies. A recent study from SelfDecode introduces Selphi, a novel imputation method with superior accuracy to existing methods, especially for rare variants. Selphi's development was accelerated using the Almaden Genomics g.nome® platform, achieving a 70% reduction in runtime and a 25-fold reduction in costs. Discover how Selphi is now advancing disease prediction and personalized medicine—read more in our latest blog post: https://lnkd.in/gvxxZP-u #genomicsequencing #imputation #genomicanalysis

📍Cambridge, MA - Almaden Genomics will be at the Biotech Vendor Services, Inc. Biotech Community Celebration at Tech Square next week on July 10! Come see us to learn how we can serve as your end-to-end #omics data analysis solution, partnering with you from data services to analysis workflows and beyond. While our g.nome® platform streamlines discovery with curated datasets, guided workflows, and interactive visualizations, our services support you through every step of your research journey. From secondary and tertiary analysis, to data provenance and reporting, bespoke pipeline development, custom interface creation, and scientific consulting, we help you deliver powerful insights quickly and efficiently. Learn more: https://lnkd.in/gxy-8DXX

Data management and the complexity of #omics analysis often hinders life sciences discoveries. The discovery process requires transparency and effective organizational systems to track and reproduce methods. Almaden Genomics is your end-to-end solution, partnering with you throughout the entire process, from data services to analysis workflows and beyond. Our platform, g.nome®, streamlines discovery with curated datasets, guided workflows, and interactive visualizations. We support every step of your research journey, offering secondary and tertiary analysis, data provenance and reporting, bespoke pipeline development, custom interface creation, and scientific consulting. Our flexible infrastructure ensures we meet your unique needs, empowering your team to deliver powerful insights quickly and efficiently. Learn more about how we can help you accelerate discovery: https://lnkd.in/gnQ9GTQb. #genomics #lifesciences #datascience #biotech

Reliability and reproducibility are essential for the credibility and efficiency of life sciences research, as well as the translation of research findings into meaningful clinical applications. Almaden Genomics’ g.nome® platform delivers traceable and reproducible results across your team and over time with robust version control and auto-generated process documentation, enabling you to meet key milestones and move seamlessly from discovery to production. g.nome provides simplified data exploration and effortless iteration so you have a higher probability of success in delivering breakthrough treatments to those in need. Learn more: https://lnkd.in/gBZvmA2H #personalizedmedicine #omicsanalysis #translationalresearch

Navigating the complexities of single-cell sequencing analysis can feel like managing a funnel, where large volumes of high-dimensional data must be distilled into meaningful insights. From quality control to visualization, each step can introduce new layers of complexity. The g.nome® platform simplifies this process by providing an end-to-end #omics analysis solution that enables scientists to select the right datasets, run pre-built workflows, dig deeper with tertiary analysis, and modify as needed along the way with complete traceability and reproducibility of results. Ready to discover how g.nome can transform your #scRNAseq analysis workflow? Watch our recent webinar to see a detailed example analysis and learn how our platform can streamline your research: https://lnkd.in/gxhMA-88 #cancerresearch #genomicsequencing

Understanding the molecular mechanisms of colorectal cancer (CRC) is crucial for advancing treatment strategies. Using g.nome®, our end-to-end #omics analysis platform, we conducted a comprehensive single-cell transcriptomics analysis with publicly accessible RNA-seq datasets, efficiently replicating the identification of key biomarkers. This analysis provides essential insights into CRC progression and the development of personalized treatments. g.nome® simplifies complex genomic analysis, reducing technical barriers and enabling researchers to derive meaningful insights quickly. By integrating powerful scRNA-seq tools like Seurat into a user-friendly interface, g.nome ensures robust data processing and analysis. Dive deeper into our study and explore how these tools facilitated our research: https://lnkd.in/g3dcWmF7 #omics #precisionmedicine #cancerresearch

Simplify NGS data processing with guided workflows on g.nome®. Wrapped in a user-friendly Q&A format, guided workflows lead users through necessary questions to streamline the analysis process. Users can easily select datasets, pair reads, use metadata for sample labeling, choose reference genomes, and set parameters. g.nome’s guided workflows offer a comprehensive summary and generate all necessary resources for processing, making it easy to manage large datasets. The platform ensures high-quality results with detailed reports, including pre-trimmed and trimmed alignment reports and multiQC reports. This streamlined process supports accurate data analysis, even with high duplicate reads. Watch our latest webinar for a case study using a publicly accessible multiple myeloma dataset, demonstrating a complete workflow from FASTQ to tertiary analysis: https://lnkd.in/gTgJvp-q #omics #scRNAseq #drugdiscovery

Colorectal cancer (CRC) is a leading cause of cancer mortality, driven by genetic and environmental factors. Genomics and differential expression analysis offer crucial insights into CRC's molecular mechanisms, aiding in #personalizedmedicine approaches. Our latest use case demonstrates how g.nome® simplifies complex #omics analysis, enabling researchers and clinicians to effortlessly conduct differential gene expression studies. By leveraging publicly available #RNAseq datasets from the Sequence Read Archive (SRA), we uncover novel genetic insights, driving future CRC research and therapeutic strategies. See how we identified potential biomarkers for early detection and prognosis of CRC, spotlighting key genes like KRT23 and ETV4. Our streamlined approach reduces technical barriers, allowing you to quickly derive meaningful insights from complex data. Read the full use case: https://lnkd.in/gkd6tRKT

✈️ The Almaden team will be traveling to Boston June 12-13 for the Festival of Genomics and Biodata. Come see us to learn how g.nome®, our end-to-end #omics data science solution, enables scientists to select the right datasets, run pre-built workflows, dig deeper with tertiary analysis, and modify as needed along the way with complete traceability and reproducibility of results. Set a meeting to learn more about how g.nome can accelerate your analysis, no matter what your skill level: https://lnkd.in/gM6GSSf7 Will we see you there? Let us know in the comments! #FOGBoston